(Press-News.org) HOUSTON – (March 18, 2025) – Erzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging, and Dr. Patrick Pilié, assistant professor of genitourinary medical oncology, were awarded $1 million by the Cancer Prevention and Research Institute of Texas (CPRIT) to develop artificial intelligence (AI) tools that can identify lethal forms of prostate cancer earlier and improve treatment selection.
Prostate cancer is the most commonly diagnosed cancer among men, yet patient outcomes vary widely. Because prostate cancer growth is fueled by male hormones, particularly testosterone, the most widely used therapies today target and block the effects of these hormones. Known as androgen signaling inhibitors, the drugs are used to slow down or shrink the cancer, but over time, some cancers adapt and develop resistance. For men with castration-resistant prostate cancer, treatment options remain limited and survival rates are poor.
Changes in cellular metabolism in cancer patients can serve as biomarkers, and the use of advanced imaging techniques to detect these changes is a promising way to monitor processes associated with sensitivity to cancer therapy and even the emergence of premalignant lesions. However, the complex nature of the data poses a challenge to traditional statistical and engineering analysis methods.
The research supported by this CPRIT grant is based on three pillars:
● Revolutionary noninvasive imaging in Bhattacharya’s laboratory produces real-time in vivo temporal and spectral profiles of tumor metabolism with unprecedented detail, which enables sensitive discrimination among different aberrant states and makes it possible to map tumor heterogeneity.
● To formally capture and model such states, Merényi’s group will apply an advanced form of AI inspired by the brain’s networks that is especially adept at discovery from intricate, high-dimensional data.
● Ongoing clinical trials of systemic therapy with androgen signaling inhibitors in a diverse population of men with prostate cancer in Pilié’s laboratory (along with mouse model data from Bhattacharya) will provide uniquely rich human data on therapeutic efficacy. The clinical data will enable the interpretation of discovered variations in metabolic signatures and help identify clinically relevant biomarkers, or biological signals, that indicate which patients carry the greatest risk of developing aggressive forms of the disease early in their diagnosis.
Successful implementation of these three pillars will allow for earlier and more precise interventions tailored to each patient’s disease profile.
An exciting key aspect of the research is how AI approaches developed and applied by Merényi’s group earlier in astronomy and Earth remote sensing can now potentially help patients with prostate cancer and other cancers in the near future. This highlights the benefits of cross-fertilization across scientific approaches in a multidisciplinary collaboration.
“Using neural map-based machine learning, we can reveal hidden patterns in the high-dimensional data, including rare or subtle patterns that may be the most important, to help clinicians detect aggressive prostate cancer earlier and make more informed treatment decisions, ultimately improving patient outcomes,” Merényi said.
By developing AI-driven models capable of handling the complexity of multimodal cancer data, the CPRIT-funded project could provide a blueprint for AI use in other areas of oncology and personalized medicine.
CPRIT leads the state’s fight against cancer, having awarded more than $3.7 billion in grants to Texas institutions and organizations through its academic research, prevention and product development research programs. CPRIT has played a critical role in recruiting top-tier researchers to Texas, supporting innovative startups and delivering millions of cancer prevention services across the state.
This latest grant underscores CPRIT’s commitment to investing in groundbreaking research that has the potential to transform cancer diagnosis and treatment.
-30-
This news release can be found online at news.rice.edu.
Follow Rice News and Media Relations via Twitter @RiceUNews.
Award information:
Title: Artificial Intelligence for Early Identification of Androgen-Indifferent, Lethal Prostate Cancer and Therapy Selection
Link: https://cprit.texas.gov/grants-funded/grants/rp250090
About Rice:
Located on a 300-acre forested campus in Houston, Texas, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of architecture, business, continuing studies, engineering and computing, humanities, music, natural sciences and social sciences and is home to the Baker Institute for Public Policy. Internationally, the university maintains the Rice Global Paris Center, a hub for innovative collaboration, research and inspired teaching located in the heart of Paris. With 4,776 undergraduates and 4,104 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 7 for best-run colleges by the Princeton Review. Rice is also rated as a best value among private universities by the Wall Street Journal and is included on Forbes’ exclusive list of “New Ivies.”
END
Rice statistician earns $1 million CPRIT award to advance AI-powered precision medicine for prostate cancer
2025-03-18
ELSE PRESS RELEASES FROM THIS DATE:
Whose air quality are we monitoring?
2025-03-18
U.S. Environmental Protection Agency (EPA) air quality monitors are disproportionally located in predominately white neighborhoods, according to University of Utah research. The EPA’s network consistently failed to capture air quality in communities of color across six major pollutants, particularly lead and sulfur dioxide, followed by ozone and carbon monoxide.
EPA regulatory monitors are the key data source driving decisions about pollution reduction, urban planning and public health initiatives. Without equal monitor distribution, the data may misrepresent pollution concentrations, leaving marginalized groups at risk.
“It’s ...
Team Hope rides (again) for cancer research at the Tour de Scottsdale
2025-03-18
For the second year in a row, Mayo Clinic physician Dr. Parminder Singh has organized a team of riders to raise funds for cancer research while tackling the 32- or 62-mile routes of the Tour de Scottsdale.
Singh is a clinical trialist with SWOG Cancer Research Network, a world-renowned organization leading cancer studies across the US and beyond. SWOG trials have led to the approval of 14 cancer drugs, changed more than 100 standards of cancer care, and saved more than 3 million years of human life.
Team Hope’s youngest rider is 11-year-old Misha Rajpal who will take on the full, ...
Researchers find missing link in autoimmune disorder
2025-03-18
Autoimmune diseases, which are estimated to affect more than 15 million people in the U.S., occur when the body responds to immune-system false alarms, and infection-fighting first responders are sent out to attack threats that aren’t there. Scientists have long understood how the false alarms get triggered, but the second step of dispatching the immune response has been a mystery.
Now, scientists at Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania ...
‘Democratizing chemical analysis’: FSU chemists use machine learning and robotics to identify chemical compositions from images
2025-03-18
TALLAHASSEE, Fla. — Florida State University chemists have created a machine learning tool that can identify the chemical composition of dried salt solutions from an image with 99% accuracy.
By using robotics to prepare thousands of samples and artificial intelligence to analyze their data, they created a simple, inexpensive tool that could expand possibilities for performing chemical analysis. The work was published in Digital Discovery.
“We are living in the age of artificial intelligence and big data,” ...
Leveraging data science for disease prediction in the fight against rheumatoid arthritis
2025-03-18
Fan Zhang, PhD, sees artificial intelligence as a pathway to finding an effective way to combat an intractable enemy: rheumatoid arthritis.
Zhang is an assistant professor in the University of Colorado Department of Medicine’s Division of Rheumatology and also is affiliated with the Department of Biomedical Informatics on the CU Anschutz Medical Campus. She recently received a highly competitive grant from the Arthritis Foundation to further her work in harnessing AI to better predict the onset of rheumatoid arthritis (RA) in particular patients, ...
Kennedy Krieger screening model improves early autism diagnosis for underserved communities
2025-03-18
BALTIMORE, March 18, 2025— A new study led by Kennedy Krieger Institute’s Center for Autism Services, Science and Innovation (CASSI) finds that a community-based screening model is helping children receive autism diagnoses faster, particularly in underserved communities.
The research, published in Pediatric Investigation, highlights how the Rapid Interactive Screening Test for Autism in Toddlers (RITA-T) is making early autism identification more accessible for families facing barriers to care. RITA-T is a quick, interactive tool that assesses developmental skills often delayed in autism, such as social engagement, ...
Blood pressure patterns during pregnancy predict later hypertension risk, study finds
2025-03-18
Women with blood pressure levels in a range considered clinically normal during pregnancy but no mid-pregnancy drop in blood pressure face an increased risk of developing hypertension in the five years after giving birth. These women—about 12% of the population studied—would not be flagged as high-risk by current medical guidelines, but the new findings could help identify them as candidates for early intervention. The findings were just published in the Journal of the American College of Cardiology: Advances.
Funded in part by the National Institutes of Health, researchers collected data on blood pressure and other health factors ...
Latest Alzheimer’s drug shown less effective in females than males
2025-03-18
Since becoming only the second Alzheimer’s-modifying drug to gain American Federal Drug Administration approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
In its Phase 3 clinical trial, lecanemab slowed cognitive decline by 27 per cent overall, yet one subset of data suggested little to no benefit in females, though the cause of the difference was not clear. An FDA committee voted unanimously that the Phrase 3 trial verified the clinical benefit of lecanemab. Even so, several follow-up papers focused on the trial’s apparent sex difference result to cast doubt on ...
Moffitt study finds vaccine may improve breast cancer treatment outcomes
2025-03-18
TAMPA, Fla. (Mar. 18, 2025) — Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown encouraging results in a recent pilot study. Published in npj Breast Cancer, the study combined the HER2-targeting dendritic cell vaccines with standard chemotherapy, demonstrating both safety and positive response rates.
The study enrolled 30 patients with stage 2 and stage 3 HER2-positive, ...
Adoption of international auditing standards leads to better financial reporting
2025-03-18
Toronto - Despite a very uncertain economic climate, investors can at least feel confident that audited financial reports are more reliable thanks to the spread of international standards.
New research led by a researcher at the University of Toronto’s Rotman School of Management shows that the quality of financial audits increasing in countries which have adopted the International Standards on Auditing, or ISA, issued through the International Federation of Accountants, the accounting profession’s worldwide body.
“We show improvement in audit quality, on average,” said researcher Ole-Kristian Hope, the Deloitte Professor of Accounting at the Rotman School. However, ...